The effect of NC-190, a novel antitumor compound, on the cell-cycle progression of HeLa S3 cells Takehiro YamagishiShiro NakaikeShigeru Tsukagoshi Original Articles Pages: 249 - 254
Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer M. Guillaume WientjesRobert A. BadalamentJessie L -S. Au Original Articles Pages: 255 - 262
Effect of vitamin A on methotrexate cytotoxicity in L1210 murine leukemia cells in culture Jun-Ichi YamamotoYashuharu NagaiShoji Awazu Original Articles Pages: 263 - 267
Randomized double-blind comparison of three dose levels of intravenous ondansetron in the prevention of cisplatin-induced emesis Steven M. GrunbergMontague LanePolly E. Sanderson Original Articles Pages: 268 - 272
Disposition of total and unbound etoposide following high-dose therapy Terry L. SchwinghammerRonald A. FlemingClinton F. Stewart Original Articles Pages: 273 - 278
Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell line Eizo KimuraRobert E. EnnsStephen B. Howell Original Articles Pages: 279 - 285
Tissue disposition, excretion and metabolism of vinblastine in mice as determined by high-performance liquid chromatography Olaf van TellingenJos H. BeijnenAuke Bult Original Articles Pages: 286 - 292
Cytotoxic properties of a new synthetic demethylpodophyllotoxin derivative, BN 58705, against human tumor cell lines Hideki MorimotoPaola PrincineBenjamin Bonavida Original Articles Pages: 293 - 300
Epirubicin metabolism and pharmacokinetics after conventional- and high-dose intravenous administration: a cross-over study Carlo M. CamaggiElena StrocchiFranco Pannuti Original Articles Pages: 301 - 309
Pharmacokinetics of PEG-l-asparaginase and plasma and cerebrospinal fluidl-asparagine concentrations in the rhesus monkey Stacey L. BergFrank M. BalisDavid G. Poplack Original Articles Pages: 310 - 314
Protection of bone-marrow granulocyte-macrophage colony-forming units in mice bearing in vivo alkylating-agent-resistant EMT-6 tumors Beverly A. TeicherDevasis ChatterjeeGulshan Ara Original Articles Pages: 315 - 319
Tumour profile ofN-[2-(dimethylamino)ethyl]acridine-4-carboxamide after intraperitoneal administration in the mouse James W. PaxtonDebbie YoungPhilip Kestell Short Communication Pages: 320 - 322
Pharmacokinetics of acridine-4-carboxamide in the rat, with extrapolation to humans James W. PaxtonDeborah YoungIain G. G. Robertson Short Communication Pages: 323 - 325
Development and initial characterization of a mitomycin C-resistant colon cancer cell line variant Roger R. PerryBridget R. GreavesYuan Kang Short Communication Pages: 326 - 328
Phase II study of fotemustine as second-line treatment after failure of immunotherapy in metastatic renal cell carcinoma Christine LasselYacine MerroucheThierry Philip Short Communication Pages: 329 - 331